Barriers to using legally authorized representatives in clinical research with older adults

Authors

Jessica Mozersky, Washington University School of Medicine in St. Louis
Erin D Solomon, Washington University School of Medicine in St. Louis
Kari Baldwin, Washington University School of Medicine in St. Louis
Matthew Wroblewski, Washington University School of Medicine in St. Louis
Meredith Parsons, Washington University School of Medicine in St. Louis
Melody Goodman, New York University
James M DuBois, Washington University School of Medicine in St. Louis

Journal

Journal of Alzheimer's Disease Reports

Publication Date

2-14-2023

Volume

7

Issue

1

First Page

135

Last Page

149

Document Type

Open Access Publication

DOI

10.3233/ADR-220103

Rights and Permissions

Mozersky J, Solomon ED, Baldwin K, Wroblewski M, Parsons M, Goodman M, DuBois JM. Barriers to Using Legally Authorized Representatives in Clinical Research with Older Adults. J Alzheimers Dis Rep. 2023 Feb 14;7(1):135-149. doi: 10.3233/ADR-220103. © 2023 – The authors. Published by IOS Press. Creative Commons License (CC BY-NC 4.0) This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Mozersky, Jessica; Solomon, Erin D; Baldwin, Kari; Wroblewski, Matthew; Parsons, Meredith; Goodman, Melody; and DuBois, James M, "Barriers to using legally authorized representatives in clinical research with older adults." Journal of Alzheimer's Disease Reports. 7, 1. 135 - 149. (2023).
https://digitalcommons.wustl.edu/oa_4/4723

Department

ICTS (Institute of Clinical and Translational Sciences)